Will COVID-19 Lead to a Resurgence of Vaccine-Preventable Diseases?
Received 12 August 2020
Accepted for publication 20 December 2020
Published 18 January 2021 Volume 2021:14 Pages 119—124
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 6
Editor who approved publication: Professor Suresh Antony
Asmita Priyadarshini Khatiwada,1 Nistha Shrestha,2 Sunil Shrestha1
1Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal; 2Department of Biostatistics and Epidemiology, University of North Texas Health Science Center, Fort Worth, TX, USA
Correspondence: Asmita Priyadarshini Khatiwada
Department of Pharmaceutical and Health Service Research, Nepal Health Research and Innovation Foundation, Lalitpur, Nepal
Abstract: The outbreak of coronavirus disease (COVID-19) has been affecting various sectors, including regular health services negatively. Vaccination, which saves the lives of 2– 3 million populations of different age groups every year, is one of the most affected services by COVID-19. The routine vaccination services and outreach programs have been halted owing to lockdowns imposed on account of escalated cases of COVID-19 all over the world, affecting millions of lives at the stake of vaccine-preventable disease (VPD) henceforth. However, as it is becoming evident that we will have to live with COVID-19 for some time and many countries have lifted the lockdown, vaccination programs and campaigns have resumed with stringent preventive measures to be followed for COVID-19. These programs and campaigns have been trying to overlook and provide the missed vaccination during the imposed lockdown period and continue the other vaccination services to the public in the best possible ways. The collaborative approaches of various health-related organisations, governments and the healthcare workers are necessary to deliver the routine and mass vaccination services in an improvised manner.
Keywords: coronavirus disease, COVID-19, immunization, vaccine preventable disease
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]